From Morphology to Clinical Insights: Ozelle’s AI-Powered Diagnostics at WHX Labs Dubai 2026
DUBAI, UAE, Feb. 10, 2026 /PRNewswire/ -- As WHX Labs Dubai 2026 opens today, visitors to Booth S1.D58 are invited to see how Ozelle transforms diagnostic testing into interactive, decision-ready workflows. Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," the integrated system combines high-resolution morphology analysis, AI-assisted workflows, and scenario-ready panels for confident clinical decision-making....
Sky Labs Launches ‘CART ON’, the World’s First Ring-Type Wearable Blood Pressure Monitoring Solution for Hospital Wards
- Establishment of a blood pressure monitoring lineup that addresses every environment, from daily life to hospital wards SEOUL, South Korea, Feb. 10, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 10th that it has launched 'CART ON', the world's first ward-specific blood pressure monitoring solution that utilizes...
Silklife: Chula Researchers Transform Thai Silk into Medical Innovation
BANGKOK, Feb. 10, 2026 /PRNewswire/ -- Researchers at Chulalongkorn University are redefining the role of Thai silk by developing silk protein into a versatile platform for medical products, aiming to reduce Thailand's reliance on imported biomaterials while creating sustainable income for farmers. Silklife: Chula Researchers Transform Thai Silk into Medical Innovation The Silklife research project,...
Medical biotech Ferronova completes enrolment for gastric and oesophageal cancer image-guided surgery trial.
ADELAIDE, Australia, Feb. 10, 2026 /PRNewswire/ -- Australian company Ferronova announced today it has completed enrolment of patients for its two-year trial to progress commercialisation of FerroTrace, a novel nanoparticle image-guided surgery solution for hard-to-treat cancers. The technology is intended to assist surgeons in identifying lymph nodes involved in metastatic spread, thereby enabling targeted removal and reducing the risk...
WAT Medical’s EmeTerm Wearable Device Demonstrates Superior Control of Moderate to Severe Postoperative Nausea and Vomiting in JAMA Surgery-Published Clinical Trial
VANCOUVER, BC, Feb. 10, 2026 /PRNewswire/ -- WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world's most reputable and high-impact surgical journals. The study confirms that the EmeTerm wristband — a wearable device utilizing transcutaneous acupoint electrical stimulation — provides significantly better control of moderate to...
MALAYSIA HEALTHCARE STRENGTHENS CROSS-BORDER COLLABORATION THROUGH STRATEGIC PARTNERSHIP WITH ONEHEALTH CAMBODIA
PHNOM PENH, Cambodia, Feb. 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) marked the launch of Malaysia Healthcare Week Phnom Penh 2026 with a hospital introduction session in collaboration with OneHealth Cambodia. This engagement represents MHTC's first official initiative in Cambodia for 2026 and forms part of the Malaysia Year of Medical Tourism (MYMT) 2026, themed "Healing Meets...
Waters Completes Combination with BD’s Biosciences & Diagnostic Solutions Businesses
Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences MILFORD, Mass., Feb. 9, 2026 /PRNewswire/...
BioDlink Recognized by Client for Enabling the World’s First Dual-Payload ADC to Enter Clinical Trials
BioDlink received a formal letter of appreciation from Chengdu Kanghong Pharmaceutical Group for its contribution to advancing KH815, the world's first dual-payload antibody–drug conjugate (ADC) to enter clinical development. BioDlink enabled IND approval 1.5 months ahead of schedule through efficient process development, manufacturing, and analytical execution. SUZHOU, China, Feb....
DIFF Biotech’s Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway
HANGZHOU, China, Feb. 9, 2026 /PRNewswire/ -- Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval as a Class 1.2 innovative vaccine from China's National Medical Products Administration (NMPA). As the first domestically self-developed nasal spray influenza vaccine in China to advance into...
‘Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma’ Book Launched in Mumbai
MUMBAI, India, Feb. 9, 2026 /PRNewswire/ -- Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and the extraordinary life of its founder, Desh Bandhu Gupta. Together, the...
